Is R 165335 Safe in Breastfeeding

I am a breastfeeding mother and i want to know if it is safe to use R 165335? Is R 165335 safe for nursing mother and child? Does R 165335 extracts into breast milk? Does R 165335 has any long term or short term side effects on infants? Can R 165335 influence milk supply or can R 165335 decrease milk supply in lactating mothers?

In the United States and other developed countries, HIV-infected mothers should generally not breastfeed their infants. In countries in which no acceptable, feasible, sustainable and safe replacement feeding is available, World Health Organization guidelines recommend that all women with an HIV infection who are pregnant or breastfeeding should be maintained on antiretroviral therapy for at least the duration of risk for mother-to-child transmission. Mothers should exclusively breastfeed their infants for the first 6 months of life; breastfeeding with complementary feeding should continue through at least 12 months of life up to 24 months of life.[1] The first choice regimen for nursing mothers is tenofovir, efavirenz and either lamivudine or emtricitabine. If these drugs are unavailable, alternative regimens include: 1) zidovudine, lamivudine and efavirenz; 2) zidovudine, lamivudine and nevirapine; or 3) tenofovir, nevirapine and either lamivudine or emtricitabine. Exclusively breastfed infants should also receive 6 weeks of prophylaxis with nevirapine.[2][3] R 165335 is excreted in breastmilk in concentrations exceeding the maternal plasma HIV inhibitory concentration.